Quarterly report pursuant to Section 13 or 15(d)

Capital Stock (Details Narrative)

v2.4.0.8
Capital Stock (Details Narrative) (USD $)
3 Months Ended 6 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Market price per share $ 15.74   $ 15.74  
Loss on early extinguishment of debt $ (1,603,400)    $ (2,371,400)   
License and maintenance fees, added to note payable     34,300  
Private Placement 2014 [Member]
       
Restricted common stock 88,750   88,750  
Exercise price $ 10.00   $ 10.00  
Placement Units 50,000   50,000  
Cash proceeds 1,775,000   1,775,000  
2013 Private Placement [Member]
       
Initial face amount 895,000   895,000  
Placement Units 93,250   93,250  
Fair value warrant 272,900   272,900  
Technology License [Member]
       
Initial face amount 300,000   300,000  
Stem cell technology license maintenance fees 288,400   288,400  
Restricted common stock 15,000   15,000  
Exercise price $ 10.00   $ 10.00  
Exercise price at grant date $ 0.22   $ 0.22  
Fair value of stock 141,000   141,000  
Fair value warrant 89,200   89,200  
Market price per share $ 9.40   $ 9.40  
Consulting Agreement for Services [Member]
       
Restricted common stock 10,000   10,000  
Fair value of stock 134,000   134,000  
Market price per share $ 13.40   $ 13.40  
Average payments for professional services 70,000   70,000  
Autilion AG [Member]
       
Purchase obligation 3,600,000   3,600,000  
Initial closing of financing $ 25,000   $ 25,000  
Initial issuance of shares under puchase agreement 2,500   2,500  
Exercise price $ 10.00   $ 10.00